Skip to content
OpenCapital
Get started

Kiniksa Pharmaceuticals International, plc KNSA Invested capital

Discontinued — last reported Q1 '26

Invested capital at other companies

Griffon logo
GriffonGFF
5.9%-9.9pp
Benchmark Electronics logo
Benchmark ElectronicsBHE
3.8%-1.7pp
Power Integrations logo
Power IntegrationsPOWI
1.5%-1.0pp
Hayward Holdings logo
Hayward HoldingsHAYW
8.3%+0.8pp
Chemours logo
ChemoursCC
-0.6%-4.1pp
United States Lime & Minerals, Inc. logo
United States Lime & Minerals, Inc.USLM
46.5%-2.9pp

Other financials

Income statement

See full
Revenue$214.3M+55.5%
Gross profit$193.5M+61.3%
Operating income$29.3M+121%
Net income$22.6M+165%
EPS (diluted)$0.27+145%

Balance sheet

See full
Cash & equivalents$190.0M+20.9%
Total debt$9.0M-9.0%
Total equity$605.7M+32.4%
Total assets$825.3M+37.7%

Cash flow

See full
Operating cash flow$50.2M+125%
CapEx$161.0K+62.6%
Free cash flow$50.0M+125%

Valuation

See full
Market cap$4.58B+128%

Profitability

See full
Gross margin89.3%+3.5pp
Operating margin12.4%+10.2pp
Net margin9.7%+7.6pp
FCF margin21.8%+12.2pp

Returns & leverage

See full
Return on equity13.7%+11.3pp
Debt / equity0×0.0×
Current ratio3.8×+0.1×

Where this comes from

Calculated from Kiniksa Pharmaceuticals International, plc’s reported figures.

$9.0Mtotal debt+$605.7Mtotal stockholders equity−$190.0Mcash and equivalents=$424.76M

The official record: Kiniksa Pharmaceuticals International, plc’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about Kiniksa Pharmaceuticals International, plc's invested capital.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Kiniksa Pharmaceuticals International, plc's invested capital?
Kiniksa Pharmaceuticals International, plc (KNSA) reported invested capital of $424.76M in Q1 2026.
How has Kiniksa Pharmaceuticals International, plc's invested capital changed year-over-year?
Kiniksa Pharmaceuticals International, plc's invested capital increased by 36.9% year-over-year, from $310.27M to $424.76M.
What is the long-term trend for Kiniksa Pharmaceuticals International, plc's invested capital?
Over 5 years (2020 to 2025), Kiniksa Pharmaceuticals International, plc's invested capital has grown at a 15.0% compound annual growth rate (CAGR), from $204.88M to $411.51M.
What does invested capital mean?
Total debt plus shareholders' equity minus cash, at the quarter end. The capital actually put to work in the operating business — the denominator of return on invested capital (ROIC).